[Attempts at treatment of acute leukemia with L-asparaginase].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013997:Time Factors
D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate
Próby leczenia ostrych białaczek L-asparaginaza.